.Merely 5 months after protecting a $one hundred million IPO, Limitless Bio is actually laying off s...
.The first phases of oncology R&D aren't short of appealing new modalities, as well as Halda Ther...
.Psychopharmacology has taken three posts regarding midstage clinical trial information determining ...
.Avidity Biosciences pleased investors along with period 1/2 data in Duchenne muscular dystrophy (DM...
.Actinogen Medical's cortisol blocker has actually skipped the major endpoint of a phase 2 research ...
.Antibody-drug conjugates (ADCs) have gone to the center of numerous a billion-dollar biobuck licens...
.Possession manager TPG, which has actually sustained biotechs like Sionna Therapies and also Santa ...
.Merck & Co.'s TIGIT plan has actually suffered one more obstacle. Months after shuttering a stag...
.After a year specified through pipe cuts, the departure of its own CEO and also cutbacks, Exscienti...
.Cullinan Therapy was impressed enough along with Port BioMed's bispecific immune system activator t...